agilon health, inc. AGL
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -198.05M | -315.66M |
| Total Depreciation and Amortization | -- | -- | -- | 10.19M | 16.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | 10.50M | 10.50M |
| Total Other Non-Cash Items | -- | -- | -- | 6.86M | 18.42M |
| Change in Net Operating Assets | -- | -- | -- | 119.85M | 211.98M |
| Cash from Operations | -- | -- | -- | -50.65M | -58.36M |
| Capital Expenditure | -- | -- | -- | -10.37M | -13.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 81.41M | 131.50M |
| Cash from Investing | -- | -- | -- | 71.04M | 117.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -1.25M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -22.00K | -178.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -2.74M | -2.74M |
| Cash from Financing | -- | -- | -- | -2.76M | -4.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 17.63M | 55.08M |